Genzyme's Challenge MS - Free, Interactive Event That Bring to Life the Challenges of Living with Multiple Sclerosis

In honor of the Joint 2014 ACTRIMS-ECTRIMS (Americas/European Committee for Treatment and Research in Multiple Sclerosis) Meeting in Boston, Genzyme – headquartered in Cambridge – is hosting Challenge MS, an interactive event to help people better understand the challenges of living with MS.

At this public event, participants will experience some of the symptoms associated with MS including vision impairment, cognitive challenges and fatigue.

For every person who participates in the Challenge MS experience, Genzyme will pledge volunteer hours that will be given back to the MS Community. Those who cannot participate in the events can Tweet a message of inspiration to the MS community @GenzymeCorp using the hashtag #GZChallengeMS. Each Tweet will count towards the total volunteer hours.

WHEN: Wednesday, September 10 & Thursday, September 11

7:00 a.m. – 7:00 p.m.

WHERE: The Food Court

The Shops at Prudential Center

800 Boylston St

Boston, MA 02199

Multiple sclerosis (MS) is estimated to affect more than 2.3 million people worldwide. MS is caused when the body’s immune system attacks the central nervous system, damaging the myelin sheath – the protective layer covering the nerves that carry signals between the brain and spinal cord and the rest of the body. It is a serious, chronic disease that impacts each person differently, with symptoms ranging from numbness in the limbs or forgetfulness to paralysis or loss of vision.

For over a decade, Genzyme and its parent company Sanofi have each been working to develop novel treatments for MS. Together, they have integrated these programs within Genzyme to establish themselves as a leader in MS. Genzyme is committed to becoming a long-term partner to the MS community by working to deliver scientific advancements and programs that will have a significant impact on the unmet needs of people living with MS.